New findings suggest using opioids and marijuana together could offer a safe way to cut opioid dosage among patients suffering from pain and thereby reduce their risk of becoming addicted to opioids.
CHICAGO – This month, dentists with advanced training in root canals known as endodontists, will get together to discuss the latest and best practices for responsibly managing a patient’s pain and the steps that can be taken to minimize the risk for prescription drug abuse.
New findings suggest rapastinel could be useful to help manage withdrawal during the critical first days after someone has entered treatment and is trying to abstain from opioid use, according to researchers.
Findings from a new mouse study suggest that treatments that increase levels of the protein thrombospondin-1 could help the liver recover from an overdose of acetaminophen.
UAB launches an emergency room-based medication assisted treatment program, which includes providing peer navigators and certifying more physicians to prescribe Suboxone in an effort to corral the opioid crisis.
In comments submitted to the federal government, the American Society of Anesthesiologists (ASA) formally supported the recommendations of the U.S. Department of Health and Human Services (HHS) Pain Management Best Practices Interagency Task Force.
A research team that includes Northern Arizona University chemistry professor Naomi Lee received an NIH grant to develop a vaccine that can blunt the effects of drugs by triggering the patient's immune system.
Johns Hopkins neuroscientists have found that the psychedelic drug MDMA reopens a kind of window, called a “critical period,” when the brain is sensitive to learning the reward value of social behaviors. The findings, reported April 3 in Nature, may explain why MDMA may be helpful in treating people with post-traumatic stress disorder (PTSD).
Embargoed press materials are now available for the Experimental Biology (EB) 2019 meeting, to be held in Orlando April 6–9. EB is the annual meeting of five scientific societies bringing together more than 12,000 scientists and 25 guest societies in one interdisciplinary community.
Fentanyl’s powerful effects are long-lasting, and even tiny amounts of the drug can lead to an overdose. Antidotes, do not last long enough in the body to fully counter the drug, requiring repeated injections. Now, scientists report that they are developing single-dose, longer-lasting opioid antidotes.
Many surgery patients head home from the hospital with opioid pain medicine prescriptions, and most will have pills left over after they finish recovering from their procedure. Now, a new study suggests patients should also leave the hospital with something to help them safely get rid of those leftovers – and keep pills from being misused or polluting the environment.
Pregnant women who use cannabis may slightly increase the risk their unborn child will develop psychosis later in life, suggests new research from Washington University in St. Louis.
Decreased sperm and testosterone production caused by abuse of performing-enhancing hormones may be fully reversible once men stop taking the drugs, but full recovery can take at least nine to 18 months, according to research to be presented Sunday, March 24 at ENDO 2019, the Endocrine Society’s annual meeting in New Orleans, La.
People under age 50 with hearing loss misuse prescription opioids at twice the rate of their hearing peers, and are also more likely to misuse alcohol and other drugs, a new national study finds. Health care providers may need to take special care when treating pain and mental health conditions in deaf and hard-of-hearing young adults.
Many people who use opioid medications long term do not produce enough testosterone or another important hormone, cortisol, according to a new study. Results of what the researchers called “the most up-to-date and most comprehensive clinical review of endocrine effects of long-term opioid use” are being presented Sunday at ENDO 2019, the Endocrine Society’s annual meeting in New Orleans, La.
A new study, published this month in Lancet HIV by Penn Medicine researchers, shows that a naltrexone implant placed under the skin was more effective at helping HIV-positive patients with an opioid addiction reduce relapse and have better HIV-related outcomes compared to the oral drug.
The American Association of Nurse Anesthetists (AANA) joins Voices for Non-Opioid Choices, a rising non-partisan coalition group dedicated to to curbing the U.S. opioids crisis by increasing patient access to non-opioid therapies and acute pain management.
Johns Hopkins researchers have discovered that use of the synthetic psychedelic 5-methocy-N,-N-dimethyltryptamine (5-MeO-DMT) appears to be associated with unintended improvements in self-reported depression and anxiety when given in a ceremonial group setting. 5-MeO-DMT is a psychedelic that is found in the venom of Bufo Alvarius toads, in a variety of plants species, and can be produced synthetically.
New insights into opioid alternatives to treat postpartum pain and medication to delay preterm labor, as well as breakthroughs in spina bifida surgery, were among the topics of research presented at the Society for Maternal-Fetal Medicine’s (SMFM) 39th Annual Pregnancy Meeting by faculty, students, and staff from UTHealth.
Analysis shows the monthly rate of first-time opioid prescriptions dropped by more than half between 2012 and 2017.
Though some physicians wrote no new prescriptions at all, others continued to prescribe dosages and durations that put patients at risk for misuse, overdose and death.
Findings underscore importance of nuanced, individualized prescribing over all-or-nothing approach.
New research presented American Academy of Orthopaedic Surgeons (AAOS) 2019 reports on the results of a major undertaking by the Department of Orthopedic Surgery at NYU Langone Health to curb opioid prescriptions and usage rates following common orthopedic procedures.
Orthopedic surgeons at Hospital for Special Surgery have developed a pain management pathway designed to reduce the use of opioid medication after joint procedures.
Young adults at risk of developing problems with addiction show key differences in an important region of the brain, according to an international team led by researchers at the University of Cambridge.
Today, the Opioid Detection Challenge, a $1.55 million USD global prize competition, was launched by DHS S&T, in collaboration with U.S. Customs and Border Protection (CBP), the Office of National Drug Control Policy (ONDCP), and the U.S. Postal Inspection Service (USPIS).
Researchers at UC San Diego School of Medicine have identified a clear group of characteristics that predict heightened risk for experiencing increased anxiety or worsening of mood that interferes with daily activities when using a smoking cessation drug. Results are published in the February 27 online edition of the Journal of General Internal Medicine.
There are two cannabinoid receptors (CB1 and CB2) in the human body that can be targeted to alleviate certain pathological conditions, including chronic pain. While the CB1 receptors are mostly found in the nervous system and are responsible for psychoactive effects, the CB2 receptors are predominantly present in the immune system. Studies indicate that CB2 is a promising target for immunotherapy, as well as treating inflammatory and neuropathic pain, and neurodegenerative diseases. It has also been shown that molecules blocking CB2 can reduce tumor growth.
Researchers at the University of New Mexico (UNM) recently solved a major gap in scientific literature by using mobile software technology to measure the real-time effects of actual cannabis-based products used by millions of people every day.
The American Psychological Association has asked the U.S. attorney general to act immediately to evaluate the more than two dozen cannabis grower applications that have been languishing for more than two years at the Department of Justice, noting that the scientific community is eager to advance the research on both the harmful and therapeutic effects of marijuana and its derivatives.
A new virtual reality physical activity intervention may be effective for people with chronic low back pain who avoid activity because of fear, helping them to become physically active once again.
Smokers are at high risk for low back pain, and also have higher rates of healthcare utilization and opioid use, and physicians should ask these patients about other comorbidities that may make their pain treatment more difficult.
A four-week interdisciplinary pain management program for worker’s compensation patients with chronic pain significantly reduced their opioid and benzodiazepine use.
UC San Diego Health is among 31 health facilities selected from across the state to participate in the California Bridge Program, an accelerated, 18-month training program for health care providers to enhance access to around-the-clock treatment for patients with opioid use disorder.
A study led by researchers at the Johns Hopkins Bloomberg School of Public Health suggests that the Food and Drug Administration (FDA) and manufacturers did not take action when evidence emerged that potentially lethal fentanyl products were being inappropriately prescribed to patients.
Collectively, assessing a snapshot of a person’s unique state of immune health is called immune profiling, which can entail identifying immune-cell-associated genes and proteins, as well as the cell types themselves.
With new findings that show an unprecedented jump in nicotine-containing electronic cigarette usage among teens, many parents wonder how best to approach the topic.
Researchers at the University of Pittsburgh School of Medicine have identified a brain protein at the root of how the brain recovers from stroke. The finding offers a promising avenue for developing therapies that could work even when given beyond the first few hours after a stroke.
A team of surgeons is working to identify the most effective strategy to treat acute pain after injury while minimizing the amount of opioids prescribed to trauma patients, building on a previous project that decreased use of the highly addictive class of drugs by 40 percent.
Building a circle of trusted adults around a suicidal teen, to support them during vulnerable times, may have long-term effects that reduce their risk of dying young, a new study suggests. About 12 years after the teens were hospitalized for suicidal behaviors, far more of the young people who got standard care had died, compared with young adults in the group that had received the extra adult support.
The Houston Emergency Response Opioid Engagement System (HEROES) was recently awarded two grants that will help fund the opioid intervention program through the end of 2020. James Langabeer, PhD, MBA, a professor at The University of Texas Health Science Center at Houston (UTHealth), created the program to provide comprehensive treatment for opioid abusers, gain a more thorough understanding of the epidemic in Houston, and work toward getting the highly addictive drugs off the streets.
The authors assess the effect of a mandatory educational program and new institutional prescriber guidelines on the behavior of physicians who prescribe opioid medications following lumbar surgery
University’s nationally-recognized Institute of Clinical Bioethics collaborates with local institutions on newly published paper proposing a model for safe injection sites designed to prevent the deaths of thousands of Philadelphians vulnerable to an opioid overdose.
A new approach to defining opioid-related auto fatalities provides insight into the nature and distribution of opioid-involved deaths in the state of Maryland, say the authors of a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health.